menu
    • menu

    Company profile for Hummingbird Bioscience

    NEW Drugs in Dev: 3
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Hummingbird Bioscience was founded in 2015 to develop better ways of generating novel therapeutic antibody-based drugs. Using rational, systems biology approaches the aim of the company is to generate therapeutic antibodies which can be deployed in precision medicine. To further this goal the company is utilizing cutting edge single cell profiling coupled with expertise in high throughput sequencing, bioinformatics and structu...
    Hummingbird Bioscience was founded in 2015 to develop better ways of generating novel therapeutic antibody-based drugs. Using rational, systems biology approaches the aim of the company is to generate therapeutic antibodies which can be deployed in precision medicine. To further this goal the company is utilizing cutting edge single cell profiling coupled with expertise in high throughput sequencing, bioinformatics and structural biology to enable our drugs to be used in the right patient at the right time.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Hummingbird BioscienceUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    329 Oyster Point Boulevard South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://hummingbirdbioscience.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/hummingbird-bioscience
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/hummingbirdbio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hummingbird Bioscience Initiates Phase I Trial For HMBD-501
    Hummingbird Bioscience Initiates Phase I Trial For HMBD-501

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213347/0/en/Hummingbird-Bioscience-Announces-First-Patient-Dosed-in-Phase-I-Clinical-Trial-of-HMBD-501-in-Advanced-HER3-Expressing-Solid-Malignancies.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Hummingbird Licenses Anti-VISTA Antibody HMBD-002 to Percheron
    Hummingbird Licenses Anti-VISTA Antibody HMBD-002 to Percheron

    25 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/26/3105519/0/en/Hummingbird-Bioscience-Licenses-HMBD-002-Phase-II-Ready-Anti-VISTA-Monoclonal-Antibody-to-Percheron-Therapeutics.html

    GLOBENEWSWIRE
    25 Jun 2025
    Share Share
    Callio Therapeutics Launches with $187M Series A
    Callio Therapeutics Launches with $187M Series A

    27 Feb 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/callio-therapeutics-launches-with-187m-series-a/

    CONTRACTPHARMA
    27 Feb 2025
    Share Share
    Hummingbird Bioscience Licenses Novel Antibodies to Immunome
    Hummingbird Bioscience Licenses Novel Antibodies to Immunome

    07 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/07/3005349/0/en/Hummingbird-Bioscience-Licenses-Novel-Antibodies-to-Immunome.html

    GLOBENEWSWIRE
    07 Jan 2025
    Share Share
    Hummingbird Bioscience Presents HMBD-802 at EORTC-NCI-AACR
    Hummingbird Bioscience Presents HMBD-802 at EORTC-NCI-AACR

    23 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/23/2967753/0/en/Hummingbird-Bioscience-Announces-Poster-Presentation-on-HMBD-802-Novel-Dual-Payload-Antibody-Drug-Conjugate-at-EORTC-NCI-AACR-2024.html

    GLOBENEWSWIRE
    23 Oct 2024
    Share Share
    Hummingbird Bioscience Appoints New CMO and COO
    Hummingbird Bioscience Appoints New CMO and COO

    29 Jul 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2024-07-29/hummingbird-bioscience-appoints-new-cmo-and-coo/9769

    CONTRACT PHARMA
    29 Jul 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search